VasDeBlock medical ApS: Financial statements 2025
CVR: 37525758
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
VasDeBlock medical ApS (CVR 37525758) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -103,154 and a net result of DKK -103,099 compared with DKK -76,186 the year before. Equity in the 2025 report amounted to DKK 79,417. The solvency ratio was 90.3%.
- Revenue
- DKK 0
- Gross Profit
- DKK -103,154
- Profit/Loss
- DKK -103,099
- Equity
- DKK 79,417
- Total Assets
- DKK 87,977
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -103K | -103K | 79K | - |
| 2024 | 0 | -76K | -76K | -6K | - |
| 2023 | 60K | -56K | -56K | 70K | - |
| 2022 | 0 | -97K | -112K | 32K | - |
| 2021 | 0 | -68K | -83K | 51K | - |
Official annual report
How creditworthy is VasDeBlock medical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
VasDeBlock medical ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -76,186.
About VasDeBlock medical ApS
VasDeBlock medical ApS is a Danish company of the type Anpartsselskab based in Karise, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mette Mikkelsen. The board consists of Nickolei Henrik Nagel (chair), Anders Brummerstedt-Madsen, Henrik Harboe and Niels Bøggild Lindeburg. The company's owners include Mette Mikkelsen, Nickolei Henrik Nagel and HOLDINGSELSKABET TEG AF 2011 ApS. In 2025, the company reported a gross profit of DKK -103,154 and a net result of DKK -103,099 compared with DKK -76,186 the year before. Equity in the 2025 report amounted to DKK 79,417.